References

Alphin, R.S. and J.W. Ward, 1967. Actions of hexopyrronium bromide on gastric secretion in dogs and on gastric secretion and ulceration in rats. Arch. Int. Pharmacodyn. Ther., 168: 82-100.
PubMed  |  

Duffin, R., C.A. Shaw and A.G. Rossi, 2008. Sildenafil reduces alcohol-induced gastric damage: Just say NO. Br. J. Pharmacol., 153: 623-624.
CrossRef  |  PubMed  |  Direct Link  |  

Elegbe, R.A., 1978. Comparative studies on starvation and indomethacin-induced ulcerations in albino rats. Biochem. Expt. Biol., 2: 159-166.
PubMed  |  Direct Link  |  

Elliott, S.N., W. McKnight, G. Cirino and J.L. Wallace, 1995. A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology, 109: 524-530.
PubMed  |  Direct Link  |  

Hirose, H., K. Takeuchi and S. Okabe, 1991. Effect of indomethacin on gastric mucosal blood flow around acetic acid-induced gastric ulcers in rats. Gastroenterology, 100: 1259-1265.
PubMed  |  Direct Link  |  

Karakaya, K., V. Hanci, S. Bektas, M. Can and H.B. Ucan et al., 2009. Mitigation of indomethacin-induced gastric mucosal lesions by a potent specific type 5 phosphodiesterase inhibitor. World J. Gastroenterol., 15: 5091-5096.

Khattab, M.M., M.Z. Gad and D. Abdallah, 2001. Protective role of nitric oxide in indomethacin-induced gastric ulceration by a mechanism independent of gastric acid secretion. Pharmacol. Res., 43: 463-467.
CrossRef  |  Direct Link  |  

Khoshakhlagh, P., M. Bahrololoumi-Shapourabadi, A. Mohammadirad, L. Ashtaral-Nakhai, B. Minaie and M. Abdollahi, 2007. Beneficial effect of phosphodiesterase-5 inhibitor in experimental inflammatory bowel disease: Molecular evidence for involvement of oxidative stress. Toxicol. Mech. Methods, 17: 281-288.
CrossRef  |  

Martin-Aragon, S., J. Benedi and A. Villar, 1994. Studies on the antiinflammatory and antiulcerogenic activities of Tuberaria lignose extracts in experimental animals. J. Pharmacol. Biol., 32: 27-32.
CrossRef  |  Direct Link  |  

Medeiros, J.V., G.G. Gadelha, S.J. Lima, J.A. Garcia and P.M. Soares et al., 2008. Role of the NO/cGMP/K(ATP) pathway in the protective effects of sildenafil against ethanol-induced gastric damage in rats. Br. J. Pharmacol., 53: 721-727.
CrossRef  |  PubMed  |  Direct Link  |  

Nakamura, C., M. Otaka, M. Odashima and S. Watanabe, 2003. Rolipram, a specific type IV phosphodiesterase inhibitor, ameliorates indomethacin-induced gastric mucosal injury in rats. Pathophysiology, 62: 449-454.
PubMed  |  Direct Link  |  

Santos, C.L., M.H. Souza, A.S. Gomes, H.P. Lemos, A.A. Santos, F.Q. Cunha and J.L. Wallace, 2005. Sildenafil prevents indomethacin-induced gastropathy in rats: Role of leukocyte adherence and gastric blood flow. Br. J. Pharmacol., 146: 481-486.
PubMed  |  Direct Link  |  

Saud, B., J. Nandi, G. Ong, S. Finocchiaro and R.A. Levine, 2005. Inhibition of TNF-α improves indomethacin-induced enteropathy in rats by modulating iNOS expression. Digestive Dis. Sci. 50: 1677-1683.
PubMed  |  Direct Link  |  

Sheehan, D.C. and B.B. Hrapchak, 1987. Theory and Practice of Histotechnology. 2nd Edn., Battelle Press, Columbus, OH., USA., ISBN: 9781574770674, Pages: 481.

Wallace, J.L. and P. del Soldato, 2003. The therapeutic potential of NO-NSAIDs. Fundam. Clin. Pharmacol., 17: 11-20.
CrossRef  |  PubMed  |  Direct Link  |  

Wallace, J.L., W. McKnight, B.K. Reuter and N. Vergnolle, 2000. NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology, 119: 706-714.
PubMed  |  Direct Link  |  

Whittle, B.J., 1977. Mechanisms underlying gastric mucosal damage induced by indomethacin and bile-salts and the actions of prostaglandins. Br. J. Pharmacol., 60: 455-460.
CrossRef  |  PubMed  |  Direct Link  |